Using genetically engineered Treg-cell-specific SRC-3 KO mice, we show that disruption of Treg SRC-3 expression leads to a complete lifetime eradication of tumors in aggressive syngeneic breast and prostate cancer models. This evidence concerns the gene NCOA3 and Familial prostate cancer.